Profiel
Patrick Loustau formerly worked at Bristol Myers Squibb Co., as Senior Vice President-Global Commercialization in 2014, Novo Nordisk A, as Senior VP-Global Marketing & Medical Affairs in 2010, and Zafgen, Inc., as President from 2014 to 2016.
Mr. Loustau received his graduate degree from Université de Paris XI Paris Sud.
Eerdere bekende functies van Patrick Loustau
| Bedrijven | Functie | Einde |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | President | 19-07-2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-04-2014 |
| NOVO NORDISK A/S | Corporate Officer/Principal | 01-07-2010 |
Opleiding van Patrick Loustau
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
| Université de Paris XI Paris Sud | Consumer Services |
